Sustained weight loss in patients treated with mifepristone for Cushing’s syndrome: a follow-up analysis of the SEISMIC study and long-term extension

BACKGROUND: Overweight and obesity are common among patients with Cushing’s syndrome (CS) and may persist in some patients even after ostensibly curative surgery, contributing to cardiometabolic dysfunction and increased cardiovascular risk. Mifepristone, a selective glucocorticoid receptor antagoni...

Descripción completa

Detalles Bibliográficos
Autores principales: Fein, Henry G., Vaughan, T. Brooks, Kushner, Harvey, Cram, David, Nguyen, Dat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624667/
https://www.ncbi.nlm.nih.gov/pubmed/26507877
http://dx.doi.org/10.1186/s12902-015-0059-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624667/
https://www.ncbi.nlm.nih.gov/pubmed/26507877
http://dx.doi.org/10.1186/s12902-015-0059-5

Ejemplares similares